Iwicki Mark T insider trades
Iwicki Mark T has filed 44 Form 4s with the SEC that we hold, for KALA BIO, Inc. (KALA) (Director), MRUS (Director), AKRO (Director) and Q32 Bio Inc. (QTTB) (Director), among 7 companies in all. Across all of them we count 0 purchases worth $0 and 12 sales worth $485.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 154,894 shares of KALA BIO, Inc. worth $125.5K, dated 2025-10-23. The first filing on our record is dated 2021-07-01 and the latest 2026-07-21.
KALA BIO, Inc. (KALA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-10-26 | S, sale reported on Form 4 | 27,598 | $49.7K | 2021-10-28 | SEC |
| 2022-01-04 | S, sale reported on Form 4 | 9,518 | $12.4K | 2022-01-05 | SEC |
| 2022-06-27 | S, sale reported on Form 4 | 7,975 | $3.0K | 2022-06-29 | SEC |
| 2022-10-26 | S, sale reported on Form 4 | 561 | $3.7K | 2022-10-28 | SEC |
| 2023-01-04 | S, sale reported on Form 4 | 198 | $5.7K | 2023-01-06 | SEC |
| 2024-01-04 | S, sale reported on Form 4 | 4,539 | $30.5K | 2024-01-05 | SEC |
| 2024-05-31 | S, sale reported on Form 4 | 7,392 | $45.0K | 2024-06-03 | SEC |
| 2024-06-26 | S, sale reported on Form 4 | 15,168 | $72.0K | 2024-06-27 | SEC |
| 2025-01-06 | S, sale reported on Form 4 | 5,779 | $44.1K | 2025-01-07 | SEC |
| 2025-06-03 | S, sale reported on Form 4 | 10,866 | $40.6K | 2025-06-05 | SEC |
| 2025-06-24 | S, sale reported on Form 4 | 13,227 | $53.0K | 2025-06-26 | SEC |
| 2025-10-23 | S, sale reported on Form 4 | 154,894 | $125.5K | 2025-10-24 | SEC |
MRUS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
AKRO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Q32 Bio Inc. (QTTB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
THRD
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Jade Biosciences, Inc. (AVTE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Inhibikase Therapeutics, Inc. (IKT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1415537) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
